腹腔镜选择性门静脉结扎术在二期肝癌肝切除术中的应用

Application of laparoscopic guided selective portal vein ligation in the two stage hepatectomy for patients with primary hepatocellular carcinoma

  • 摘要: 目的 探讨腹腔镜选择性门静脉结扎术在二期肝癌肝切除术中的临床应用价值。方法 回顾性分析2009年3月至2012年2月四川省人民医院收治的23例无法一期手术切除的原发性肝癌患者的临床资料。先行腹腔镜选择性门静脉结扎术,术后3~4周,经CT检查了解各肝叶体积及预计肝切除体积的动态变化,评估肝癌可切除性后再行二期开腹肝癌肝切除术。组间比较采用方差分析,两两比较采用q检验(方差不齐数据行对数转换)。结果 选择性门静脉结扎术:23例患者均行门静脉右支结扎,其中22例于腹腔镜下成功结扎门静脉右支(2例因暴露门静脉右支困难,同时行胆囊切除),1例患者因分离门静脉时出血,中转开腹行门静脉右支结扎。3例多发肿瘤患者行腹腔镜选择性门静脉结扎后1周加行TACE,其中2例行右半肝切除+健侧肝脏肿瘤RFA治疗。23例患者术后出现不同程度的肝区隐痛不适、低热、恶心、呕吐等非特异性反应,无腹腔出血、胆汁漏、肝脓肿等并发症发生;术后出现程度不同的肝功能损害,术后1周AST、ALT和TBil恢复至术前水平。术后右半肝体积逐渐缩小,术后3周患者右半肝体积为(590±154)cm3,较术前(698±135)cm3明显缩小,术前与术后右半肝体积比较,差异有统计学意义(F=15.62,P0.05);术后3周左半肝体积为(408±149)cm3,较术前(331±68)cm3增生,术前与术后左半肝体积比较,差异有统计学意义(F=17.48,P<0.05);预计肝切除体积占全肝体积百分比由术前的67%15%缩小至术后3周时的60%±18%,术前与术后1、2、3周预计肝切除体积占全肝体积百分比比较,差异有统计学意义(F=12.35,P<0.05)。二期肝癌肝切除术:经CT检查评估后,23例患者中,2例因左半肝增生不明显、2例因术后(其中1例患者术前健侧肝脏发现转移癌)3周出现广泛肝内转移失去手术机会,2例失访,3例主动放弃二期肝癌肝切除术,14例在腹腔镜选择性门静脉结扎术后2~4周行二期肝癌肝切除术。手术切除率为60.9%(14/23)。其中扩大右半肝切除2例、右半肝切除8例、不规则右半肝切除4例。二期肝癌肝切除术后患者恢复良好,无肝衰竭、严重腹腔积液、腹腔内感染等严重并发症发生,康复出院。结论 腹腔镜选择性门静脉结扎术治疗后预留剩余肝脏增生,使部分肝癌患者获得二期手术机会,且二期肝癌肝切除术后患者恢复良好。

     

    Abstract: Objective To investigate laparoscopicguided selective portal vein ligation in the twostage hepatectomy for patients with primary hepatocellular carcinoma (HCC). Methods Twentythree patients with HCC who were not suitable for onestage hepatectomy were admitted to the Sichuan Provincial People′s Hospital from March 2009 to February 2012. Their clinical data were retrospectively analyzed. Laparoscopicguided selective portal vein ligation was firstly performed, dynamic changes of hepatic volume and predicted volume of liver to be resected were detected by computed tomography. Twostage open hepatectomy was performed after assessment of resectability of HCC. All data were analyzed using the analysis of variance or q test. Results Laparoscopicguided selective portal vein ligation was successfully performed on 22 patients (2 patients received concomitant cholecystectomy because the right branch of portal vein was difficult to expose), 1 patient was converted to open surgery because of hemorrhage during portal vein separation. Three patients with multiple  lesions received transcatheter arterial chemoembolization at 1 week after selective portal vein ligation. Dull pain in the hepatic region, low fever, nausea and vomiting were observed in the 23 patients, while no severe complications including peritoneal hemorrhage, bile leakage, hepatapostema was observed. The levels of aspartate aminotransferase, alanine aminotransferase and total bilirubin were back to normal at 1 week after the surgery. The right liver volume at postoperative week 3 was (590±154)cm3, which was significantly smaller than (698±135)cm3 before surgery. Compared with right liver volume at postoperative week 1, 2, 3, the right liver volume before operation was significantly smaller F=15.62, P<0.05). The left hepatic volume at postoperative week 3 was (408±149)cm3, which was significantly bigger than (331±68)cm3 before operation. The left liver volume before operation was significantly different from those at postoperative week 1, 2, 3 (F=17.48, P0.05). The predicted ratio of liver to be resected was 60%±18% at postoperative week 3, which was significantly smaller than 67%±15% before operation (F=12.35, P<0.05). Two patients with insufficient hyperplasia of offside liver, 2 patients with intrahepatic metastasis at postoperative week 3, 2 patients were lost to follow up and 3 patients gave up hepatectomy, 14 patients received hepatectomy at 24 weeks after laparoscopicguided selective portal vein ligation. The resection rate was 60.9%(14/23). There were 2 patients received extended right hepatectomy, 8 received right hepatectomy, 4 received nonanatomical hepatectomy. All the 14 patients recovered well, and no hepatic failure, severe peritoneal effusion and infection was observed. Conclusion Laparoscopicguided selective portal vein ligation is easy to perform, and it extends the indication of hepatectomy, increases the safety of twostage hepatectomy.

     

/

返回文章
返回